Light Science Technologies achieves positive EBITDA with expanding margins. WATCH the interview here.

Less Ads, More Data, More Tools Register for FREE

AstraZeneca's Farxiga approved to treat paediatric type-2 diabetes

Wed, 12th Jun 2024 20:56

(Alliance News) - AstraZeneca PLC on Wednesday said its Farxiga treatment has been approved in the US to treat some diabetes sufferers.

The pharmaceutical firm said the drug has been backed by the US Food & Drug Administration to treat patients aged 10 years and older with type-2 diabetes.

"Farxiga was previously approved in the US in adults with T2D as an adjunct to diet and exercise to improve glycaemic control," AstraZeneca said.

"Additional regulatory submissions and rollout plans are under consideration pending further market evaluations."

Shares in the company closed 0.6% higher at 12,446.00 pence each in London on Wednesday.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
10 Jul 2024 10:08

LONDON BROKER RATINGS: Barclays raises Kerry, cuts Hunting, Wood Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

5 Jul 2024 08:36

TOP NEWS: AstraZeneca drug Tagrisso gets EU approval for cancer form

(Alliance News) - AstraZeneca PLC on Friday announced that its medication osimertinib, alongside chemotherapy, has been approved by the European Commi...

3 Jul 2024 09:57

Aptamer shares jump as inks agreement with AstraZeneca

(Alliance News) - Aptamer Group PLC on Wednesday said it reached an agreement with AstraZeneca PLC.

2 Jul 2024 09:47

LONDON BROKER RATINGS: Deutsche Bank cuts Quilter, ups Polar Capital

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

1 Jul 2024 09:13

TOP NEWS: AstraZeneca cancer and Covid drugs recommended for approval

(Alliance News) - AstraZeneca PLC on Monday said two cancer treatments had been recommended for approval in the European Union, while there was also p...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.